Capabilities · Oral solid dosage forms

Pellets & multiparticulates

A proposed service domain for complex multiparticulate forms, connecting core generation, functional coating, process analytical technology and final presentation.

PlannedCatalogue scope

Illustrative unbranded uncoated tablet detail.
Illustrative unbranded uncoated tablet detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Pellets and multiparticulates are presented as a planned service area. The specific active substance, required release profile and precise manufacturing technology would set the scope.

The initial facility plan focuses on parenteral production modules. Multiparticulate presentations constitute a separate catalogue proposal, and their advancement would demand extensive technical confirmation before any service could commence.

Extrusion, spheronisation and fluid-bed coating involve distinct process dynamics. Inclusion in this catalogue does not demonstrate that a proposed facility would suit a specific multiparticulate formulation.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Uncoated core pelletsProposed intermediate presentation for subsequent processing; not established by the initial plan.Catalogue scopePlanned
Functional coated multiparticulatesFormat requiring specific coating layers; would need independent scope confirmation.Catalogue scopePlanned
Pellets in hard capsulesHard capsulesProposed combined presentation; requires separate evidence for capsule filling operations.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Material preparation & dispensing

Define active components, excipient properties and the precise material allocation for multiparticulate processing.

02 · Process stage

Planned

Core generation & sizing

Consider extrusion, spheronisation or layering techniques to create the initial structural pellet core.

03 · Process stage

Planned

Drying & process monitoring

Establish moisture reduction parameters, physical checks and appropriate control limits for intermediate materials.

04 · Process stage

Planned

Functional polymer coating

Define the fluid-bed parameters, spray rates and temperature controls required for the coating.

05 · Process stage

Planned

Final particle characterisation

Assess the finished size distribution, surface properties and relevant intermediate acceptance criteria.

06 · Process stage

Planned

Packaging or capsule filling

Connect the finished particulates with primary packaging systems or subsequent capsule filling equipment.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Modified-release & oral films

Product-specific release design and film presentations; performance cannot be inferred.

Explore proposed scope

03PlannedCatalogue scope

Process development & scale-up

Process definition, scale considerations and the evidence needed for transfer.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product & functional profile
Exact multiparticulate formulation, physical characteristics and the intended release profile.
Facility & process systems
Relevant installed generation systems, coating qualification and an approved scope.
Manufacturing evidence
Defined operating parameters, appropriate validation and the required process controls.
Quality & analytical roles
Controlled documentation, specific analytical scope, review and technical decision rights.
Regulatory documentation context
Applicable site and product permissions for the intended multiparticulate activity.
Technical engagement agreement
Responsibilities, analytical disclosure and boundaries for any future multiparticulate project.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating pellet or multiparticulate service.

Does the facility plan include these formats?

No. The initial plan identifies specific injectable formats. Pellets, multiparticulates and other oral forms in the wider catalogue require separate scope confirmation.

What information helps define the question?

Identify the proposed particulate formulation, release target, development stage, intended destination and the technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, permissions, process evidence and any technical agreement would need to be established before a service or supply commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma